ACLY and COVID-19: Even in the case of aPL positivity, LA as well as “solid-phase” antibodies, such as aCL and aβ2GPI, might be a feature of the SARS-CoV-2 infection as previously reviewed; the data regarding their role in thrombosis occurrence during COVID-19 remains scarce and inconclusive [6,7].